Dr. Rafat Abonour from the Indiana University Simon Cancer Center, talks about the multiple myeloma highlights presented at the annual American Society of of Hematologists (ASH) meeting in San Diego, CA.


ABOUT RAFAT ABONOUR, MD

Dr. Rafat Abonour holds the title of Professor of Medicine; Professor of Pathology & Laboratory Medicine; Medical Director, Bone Marrow Transplant Program; and Medical Director, Stem Cell Laboratory at the Simon Cancer Center at Indiana University in Indianapolis. His work has been published in the medical journal Nature and New England Journal of Medicine, among others. He focuses on changing research using immunomodulatory drugs (IMiDs) and proteasome inhibitors for the treatment of multiple myeloma. He is active with the International Myeloma Foundation and the American Society of Hematology (ASH). View Dr. Rafat Abonour’s full biography. Visit Dr. Rafat Abonour’s full biography.

Previous Post
Proposed 2019 treatment algorithms for Multiple Myeloma
Next Post
ASH 2018 Top Multiple Myeloma Research - Luciano Costa

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.